Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 1,193.00
+27.00 (2.32%)
At close: Oct 29, 2026
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 92.76 billion as of October 28, 2026. It is the 27,839th most valuable company in the world and the 1,326th biggest in South Korea. Its market cap has decreased by 61.33% in one year.
Market Cap
92.76B
Enterprise Value
187.12B
Revenue
26.67B
Global Rank
Country Rank
#1,326 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 92.76B, a decrease of -84.87%. That is a compound annual growth rate of -28.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 92.76B | -60.69% |
| Dec 30, 2025 | 235.98B | -40.12% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kanaph Therapeutics | 130.74B |
| TiumBio | 121.51B |
| Ensol Biosciences | 119.76B |
| ViGenCell | 103.93B |
| Cell Biotech | 102.66B |
| AriBioLab | 100.43B |
| Choong Ang Vaccine Laboratory | 81.46B |
| BIO-FD&C | 76.35B |